Research location
Gera
Germany
Advertisement
Research activity in Gera
GermanyCureCurrent currently publishes aggregate city-level research activity for this location: 95 trials and 105 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Gera
95 linked trials · page 2 of 2Effectiveness Study of Nivolumab Compared to Chemotherapy in Patients With Relapsed Small-cell Lung CancerNCT02481830 · 2015-09-14 · 1 site observation
COMPLETED
A Study of Abemaciclib (LY2835219) in Participants With Stage IV Squamous Non-small Cell Lung CancerNCT02450539 · 2015-08-06 · 1 site observation
COMPLETED
An Investigational Immuno-therapy Trial of Nivolumab, or Nivolumab Plus Ipilimumab, or Nivolumab Plus Platinum-doublet Chemotherapy, Compared to Platinum Doublet Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC)NCT02477826 · 2015-08-05 · 1 site observation
COMPLETED
A Study of Atezolizumab in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin+Nab-Paclitaxel in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)NCT02367781 · 2015-04-16 · 1 site observation
COMPLETED
Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular LeadsNCT02290028 · 2014-12-16 · 1 site observation
TERMINATED
A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung CancerNCT02152631 · 2014-10-03 · 1 site observation
ACTIVE_NOT_RECRUITING
Iperia/Sentus QP StudyNCT02181686 · 2014-07-01 · 1 site observation
COMPLETED
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast CancerNCT02032823 · 2014-04-22 · 1 site observation
ACTIVE_NOT_RECRUITING
Clinical Study to Investigate the Efficacy and Safety of Two Dose Levels of NT 201 Versus Placebo in Treating Chronic Troublesome Sialorrhea in Various Neurological ConditionsNCT02091739 · 2014-04-01 · 1 site observation
COMPLETED
Effect of Serelaxin Versus Standard of Care in Acute Heart Failure (AHF) PatientsNCT02064868 · 2014-01-31 · 1 site observation
TERMINATED
Azilect® In Wearing-Off (AIWO)NCT02384512 · 2014-01-01 · 1 site observation
COMPLETED
Telemedical Interventional Management in Heart Failure IINCT01878630 · 2013-08-08 · 1 site observation
COMPLETED
Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated PainNCT01744496 · 2012-11-01 · 1 site observation
COMPLETED
A Study of Pertuzumab in Combination With Trastuzumab (Herceptin) and a Taxane in First-Line Treatment in Participants With Human Epidermal Growth Factor 2 (HER2)-Positive Advanced Breast CancerNCT01572038 · 2012-06-01 · 1 site observation
COMPLETED
4EVER - Efficacy, Safety, Health Economics, Translational Research of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast CancerNCT01626222 · 2012-06-01 · 1 site observation
COMPLETED
Observational Study With Neupro® to Evaluate the Patient´s Perception of Pain Associated With Parkinson´s DiseaseNCT01606670 · 2012-05-01 · 1 site observation
COMPLETED
Efficacy and Safety of Intraseasonal Specific Immunotherapy With Depiquick® BirchNCT01902992 · 2012-03-01 · 1 site observation
COMPLETED
Safety and Efficacy of AQW051 in L-dopa Induced Dyskinesias in Patients With Parkinson's DiseaseNCT01474421 · 2011-09-15 · 1 site observation
COMPLETED
A Study of Bevacizumab in Combination With Standard of Care Treatment in Participants With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC)NCT01351415 · 2011-06-25 · 1 site observation
COMPLETED
Study to Compare Adhesiveness of Two Different Rotigotine Patch FormulationsNCT01338896 · 2011-04-01 · 1 site observation
COMPLETED
Abiliti™ Treatment in Obese SubjectsNCT01448785 · 2011-04-01 · 1 site observation
UNKNOWN
A Treatment With Fulvestrant and Exemestane in Postmenopausal Patients With Advanced Hormone Receptor-Positive (HR) + Breast CancerNCT01171417 · 2010-08-01 · 1 site observation
COMPLETED
Quality of Life in Daxas-treated Patients Older Than 18 Years With Severe COPDNCT01285180 · 2010-08-01 · 5 site observations
COMPLETED
Change in Gastrointestinal Complaints After Switch From Oral Parkinson's Disease Treatment to Neupro® Transdermal PatchNCT01159691 · 2010-06-01 · 1 site observation
COMPLETED
Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating FactorNCT01459653 · 2010-03-01 · 1 site observation
COMPLETED
Assessment of Chronic Obstructive Pulmonary Disease (COPD) Therapy From the Physicians Perspective Using Tiotropium as an ExampleNCT01036763 · 2010-01-01 · 1 site observation
COMPLETED
ADAGIO Follow Up Study: Evaluation of the Long-Term Effects of Rasagiline in Parkinson's Disease SubjectsNCT00936676 · 2009-07-01 · 1 site observation
COMPLETED
Effectiveness and Safety of Firmagon®NCT00930319 · 2009-06-01 · 1 site observation
COMPLETED
Duloxetine in Patients With Diabetic in Peripheral Neuropathic Pain With or Without Co-morbid Major Depressive DisorderNCT00844194 · 2009-02-01 · 1 site observation
COMPLETED
Non-interventional Observational Study on WHO-5 Questionnaire Application in Parkinson's DiseaseNCT00752388 · 2008-11-01 · 1 site observation
COMPLETED
Long-term Safety Study of Open-label Pramipexole Extended Release (ER) in Patients With Early Parkinson´s Disease (PD).NCT00601523 · 2008-01-01 · 1 site observation
COMPLETED
Overnight Switch Trial From Pramipexole IR to Pramipexole ER in Patients With Early Parkinson DiseaseNCT00558025 · 2007-10-01 · 1 site observation
COMPLETED
ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063DNCT00490139 · 2007-05-16 · 1 site observation
COMPLETED
Non-interventional Observational Study With Pramipexole: Impact on Non-motor Symptoms in Parkinson's DiseaseNCT00539214 · 2007-03-01 · 1 site observation
COMPLETED
Observational Non-interventional Study (Anwendungsbeobachtung) With Telmisartan in High-risk HypertensivesNCT00539487 · 2007-01-01 · 7 site observations
COMPLETED
Transdermal Rotigotine User Surveillance StudyNCT00599339 · 2006-06-01 · 1 site observation
COMPLETED
Study of (Mirapex) Pramipexole for the Early Treatment of Parkinsons Disease (PD)NCT00321854 · 2006-05-01 · 1 site observation
COMPLETED
Profile of Depressive Symptoms in Parkinsons DiseaseNCT00349310 · 2006-04-01 · 1 site observation
COMPLETED
Letrozole as Early Adjuvant Treatment of Postmenopausal Patients With Primary Breast CancerNCT00332852 · 2006-03-01 · 1 site observation
COMPLETED
Pramipexole Versus Placebo in Parkinson's Disease (PD) Patients With Depressive SymptomsNCT00297778 · 2006-03-01 · 1 site observation
COMPLETED
A Study of the Efficacy and Safety of Pregabalin for the Treatment of Diabetic Peripheral Neuropathy or Postherpetic NeuralgiaNCT00629681 · 2004-11-01 · 1 site observation
COMPLETED
Efficacy and Safety of Adalimumab in Patients With Rheumatoid Arthritis in Routine Clinical PracticeNCT01077258 · 2004-04-01 · 1 site observation
COMPLETED
Study Evaluating Sumanirole for the Treatment of the Signs and Symptoms of Early Parkinson's DiseaseNCT00058838 · 2003-04-01 · 1 site observation
COMPLETED
A Randomized, Double-blind, Placebo-controlled, Five Parallel Groups Efficacy and Safety Study of NS 2330 (Tesofensine) (0.125 mg, 0.25 mg, 0.5 mg and 1.0 mg) Administered Orally Once Daily Over 14 Weeks in Levodopa Treated Parkinson Patients With Motor FluctuationsNCT00148512 · 2003-03-01 · 1 site observation
COMPLETED
Randomized Trial Of Exemestane Versus Continued Tamoxifen In Postmenopausal Women With Early Breast CancerNCT00038467 · 1998-02-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.